
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?
Author(s) -
Frédérique Ponchel,
Myrthe A. M. van Delft,
Xuanxiao Xie,
Agata Burska,
Laurence Duquenne,
Leendert A. Trouw,
Paul Emery
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/u891rd
Subject(s) - medicine , rheumatoid arthritis , context (archaeology) , gastroenterology , carp , arthritis , odds ratio , antibody , immunology , fish <actinopterygii> , paleontology , fishery , biology
ACR/EULAR-2010 classification criteria for rheumatoid arthritis (RA) rely heavily on the presence of anti-citrullinated peptide antibody (ACPA). The role of anti-carbamylated protein antibodies (anti-CarP) in this context is uncertain. We aimed to investigate the value of anti-CarP for RA classification in patients with early inflammatory arthritis.